(Q38443012)

3 September 2017

title

Tau protein in cerebrospinal fluid from semantic dementia patients (English)

1 reference

3 September 2017

0 references

1 reference

Andersen C

1

1 reference

3 September 2017

Froelich Fabre S

2

1 reference

3 September 2017

Ostberg P

3

1 reference

3 September 2017

Lannfelt L

4

1 reference

3 September 2017

Wahlund L

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

3 September 2017

1 reference

3 September 2017

volume

294

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

155-158

1 reference

Bilateral temporal lobe volume reduction parallels cognitive impairment in progressive aphasia.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Tau mutations cause frontotemporal dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Progressive aphasia: a precursor of global dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Increased cerebrospinal fluid tau in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Apolipoprotein E genotypes in primary progressive aphasia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

A voxel-based morphometry study of semantic dementia: Relationship between temporal lobe atrophy and semantic memory

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Apolipoprotein E allelic frequencies in patients with lobar atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Frontotemporal Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Phenotypic variation in hereditary frontotemporal dementia with tau mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

Tau mutations in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901566-4

7 January 2021

10.1016/S0304-3940(00)01566-4

Identifiers

DOI

1 reference

3 September 2017

1 reference